|
SAP18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.14273043752655E-14 |
| Normal-vs-Stage2 |
8.20009999999982E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62536650805123E-12 |
| Stage1-vs-Stage2 |
2.140600E-01 |
| Stage1-vs-Stage3 |
4.995500E-03 |
| Stage1-vs-Stage4 |
1.924370E-02 |
| Stage2-vs-Stage3 |
7.761400E-03 |
| Stage2-vs-Stage4 |
1.402110E-02 |
| Stage3-vs-Stage4 |
8.603800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.6981000000087E-05 |
| Normal-vs-Asian |
4.44399961274655E-10 |
| Caucasian-vs-AfricanAmerican |
4.600000E-01 |
| Caucasian-vs-Asian |
1.131760E-01 |
| AfricanAmerican-vs-Asian |
8.737800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33146835171283E-14 |
| Normal-vs-Female |
1.62558855265615E-12 |
| Male-vs-Female |
7.147200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62658775337832E-12 |
| Normal-vs-Age(41-60Yrs) |
1.63069557856943E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64035451888367E-12 |
| Normal-vs-Age(81-100Yrs) |
4.52049999988269E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.031600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.792830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.085200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.662800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.311190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.673800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.258400E-02 |
| Classical-VS-Follicular |
1.724670E-03 |
| Classical-VS-Other |
2.666200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.77500000000586E-05 |
| Tall-VS-Other |
5.765800E-02 |
| Tall-VS-Normal |
1.70941039101535E-12 |
| Follicular-VS-Other |
1.871380E-01 |
| Follicular-VS-Normal |
2.19949999999969E-05 |
| Other-VS-Normal |
2.04149999999403E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33892896769794E-13 |
| Normal-vs-N1 |
4.44089209850063E-15 |
| N0-vs-N1 |
7.399700E-02 |
|
|
